Related Experiment Video
Updated: Jan 24, 2026

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Antiaging Therapies, Cognitive Impairment, and Dementia
Devin Wahl1,2, Rozalyn M Anderson3,4, David G Le Couteur1,2
1Charles Perkins Centre.
Abstract:
Aging is a powerful risk factor for the development of many chronic diseases including dementia. Research based on disease models of dementia have yet to yield effective treatments, therefore it is opportune to consider whether the aging process itself might be a potential therapeutic target for the treatment and prevention of dementia. Numerous cellular and molecular pathways have been implicated in the aging process and compounds that target these processes are being developed to slow aging and delay the onset of age-associated conditions. A few particularly promising therapeutic agents have been shown to influence many of the main hallmarks of aging and increase life span in rodents. Here we discuss the evidence that some of these antiaging compounds may beneficially affect brain aging and thereby lower the risk for dementia.
Insights
Aging accelerates dementia risk. Targeting aging pathways with specific compounds may offer new therapeutic strategies for dementia prevention and treatment by promoting healthier brain aging.
Area of Science:
- Gerontology
- Neuroscience
- Pharmacology
Background:
- Aging is a primary risk factor for chronic diseases, including dementia.
- Current dementia treatments targeting disease models are limited.
- The aging process itself is emerging as a potential therapeutic target for dementia.
Purpose of the Study:
- To explore the potential of targeting the aging process for dementia treatment and prevention.
- To review anti-aging compounds and their effects on brain aging and dementia risk.
Main Methods:
- Review of existing research on cellular and molecular pathways implicated in aging.
- Analysis of studies on compounds designed to slow aging and extend lifespan.
- Evaluation of evidence for the impact of anti-aging agents on brain aging.
Main Results:
- Numerous cellular and molecular pathways are linked to aging.
- Several compounds show promise in slowing aging and increasing lifespan in animal models.
- Emerging evidence suggests some anti-aging compounds may benefit brain aging.
Conclusions:
- Targeting fundamental aging processes offers a novel approach to dementia prevention.
- Anti-aging compounds may hold potential for mitigating age-related cognitive decline.
- Further research into anti-aging interventions could lead to new dementia therapies.
More Related Videos
Related Concept Videos
Cognitive Therapy
Beck's Cognitive Therapy
Arbitrary Inference
Arbitrary inference involves making conclusions without sufficient...
Dementia
The progression of dementia is generally gradual....
Cognitive Dissonance
Gene Therapy
Language and Cognition

